Injectable kartogenin and apocynin loaded micelle enhances the alleviation of intervertebral disc degeneration by adipose-derived stem cell
Source abstract
Abstract
Cell transplantation has been proved the promising therapeutic effects on intervertebral disc degeneration (IVDD). However, the increased levels of reactive oxygen species (ROS) in the degenerated region will impede the efficiency of human adipose-derived stem cells (human ADSCs) transplantation therapy. It inhibits human ADSCs proliferation, and increases human ADSCs apoptosis. Herein, we firstly devised a novel amphiphilic copolymer PEG-PAPO, which could self-assemble into a nanosized micelle and load lipophilic kartogenin (KGN), as a single complex (PAKM). It was an injectable esterase-responsive micelle, and showed controlled release ability of KGN and apocynin (APO). Oxidative stimulation promoted the esterase activity in human ADSCs, which accelerate degradation of esterase-responsive micelle. Compared its monomer, the PAKM micelle possessed better bioactivities, which were attributed to their synergistic effect. It enhanced the viability, autophagic activation (P62, LC3 II), ECM-related transcription factor (SOX9), and ECM (Collagen II, Aggrecan) maintenance in human ADSCs. Furthermore, it is demonstrated that the injection of PAKM with human ADSCs yielded higher disc height and water content in rats. Therefore, PAKM micelles perform promoting cell survival and differentiation effects, and may be a potential therapeutic agent for IVDD.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Spine and Intervertebral Disc Pathology · Spinal Hematomas and Complications · Musculoskeletal pain and rehabilitation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (51)
Show source-provided references
1. Expenditures and health status among adults with back and neck problems10.1001/jama.299.6.656 ↗
2. Does lumbar disc degeneration on magnetic resonance imaging associate with low back symptom severity in young Finnish adults?10.1097/BRS.0b013e3182077122 ↗
3. Intervertebral disc: anatomy-physiology-pathophysiology-treatment10.1111/j.1533-2500.2007.00171.x ↗
4. Biomaterials for intervertebral disc regeneration and repair10.1016/j.biomaterials.2017.03.013 ↗
5. Human intervertebral disc: structure and function10.1002/ar.1092200402 ↗
6. Stem cell therapy for intervertebral disc regeneration: obstacles and solutions10.1038/nrrheum.2015.13 ↗
7. Cell-based strategies for IVD repair: clinical progress and translational obstacles10.1038/s41584-020-00568-w ↗
8. Mesenchymal stem cells in regenerative medicine: focus on articular cartilage and intervertebral disc regeneration10.1016/j.ymeth.2015.09.015 ↗
9. Sustained release of GDF5 from a designed coacervate attenuates disc degeneration in a rat model10.1016/j.actbio.2019.01.028 ↗
10. Stem cell therapies for intervertebral disc degeneration: immune privilege reinforcement by fas/FasL regulating machinery10.2174/1574888X10666150416114027 ↗
11. Influence of collagen type II and nucleus pulposus cells on aggregation and differentiation of adipose tissue-derived stem cells10.1111/j.1582-4934.2008.00278.x ↗
12. Regeneration of intervertebral disc by mesenchymal stem cells: potentials, limitations, and future direction10.1007/s00586-006-0183-z ↗
13. Responses of human adipose-derived mesenchymal stem cells to chemical microenvironment of the intervertebral disc10.1186/1479-5876-10-49 ↗
14. Heme oxygenase-1-mediated autophagy protects against oxidative damage in rat nucleus pulposus-derived mesenchymal stem cells
15. Aging, inflammation, stem cells, and bone healing10.1186/s13287-016-0300-9 ↗
16. Replicative senescence of mesenchymal stem cells: a continuous and organized process10.1371/journal.pone.0002213 ↗
17. Apocynin: molecular aptitudes10.1155/2008/106507 ↗
18. Detection of superoxide and NADPH oxidase in porcine articular chondrocytes10.1016/S0891-5849(97)00054-3 ↗
19. Apocynin prevents cyclooxygenase 2 expression in human monocytes through NADPH oxidase and glutathione redox-dependent mechanisms10.1016/j.freeradbiomed.2004.04.020 ↗
20. Effect of apocynin on ozone-induced airway hyperresponsiveness to methacholine in asthmatics10.1016/S0891-5849(01)00725-0 ↗
21. Oral administration of the NADPH-oxidase inhibitor apocynin partially restores diminished cartilage proteoglycan synthesis and reduces inflammation in mice10.1016/j.ejphar.2005.11.061 ↗
22. The oxidation of apocynin catalyzed by myeloperoxidase: proposal for NADPH oxidase inhibition10.1016/j.abb.2006.11.010 ↗
23. Effect of pretreatment with the NADPH oxidase inhibitor apocynin on the therapeutic efficacy of human placenta-derived mesenchymal stem cells in intracerebral hemorrhage10.3390/ijms19113679 ↗
24. Blocking Nox 2 improves mesenchymal stem cells therapy in myocardial infarction via antagonizing oxidant and promoting survival10.1002/jcp.26623 ↗
25. Development of kartogenin-conjugated chitosan-hyaluronic acid hydrogel for nucleus pulposus regeneration10.1039/C7BM00001D ↗
26. Polymer nanoparticles via living radical polymerization in aqueous dispersions: design and applications10.1021/ma300170c ↗
27. A simple disc degeneration model induced by percutaneous needle puncture in the rat tail10.1097/BRS.0b013e31817c64a9 ↗
28. Magnetic resonance classification of lumbar intervertebral disc degeneration10.1097/00007632-200109010-00011 ↗
29. The effect of injection volume on disc degeneration in a rat tail model10.1097/BRS.0b013e3182027d42 ↗
30. Genipin cross-linked type II collagen/chondroitin sulfate composite hydrogel-like cell delivery system induces differentiation of adipose-derived stem cells and regenerates degenerated nucleus pulposus10.1016/j.actbio.2018.03.019 ↗
31. Scar tissue-targeting polymer micelle for spinal cord injury treatment10.1002/smll.201906415 ↗
32. Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc10.1002/path.1608 ↗
33. The effects of short-term load duration on anabolic and catabolic gene expression in the rat tail intervertebral disc10.1016/j.orthres.2005.01.020 ↗
34. Changes in gene expression and protein distribution at different stages of mechanically induced disc degeneration--an in vivo study on the New Zealand white rabbit10.1002/jor.20055 ↗
35. Metformin decreases LPS-induced inflammatory response in rabbit annulus fibrosus stem/progenitor cells by blocking HMGB1 release10.18632/aging.102453 ↗
36. Sox9 deletion causes severe intervertebral disc degeneration characterized by apoptosis, matrix remodeling, and compartment-specific transcriptomic changes10.1016/j.matbio.2020.09.003 ↗
37. In search of nucleus pulposus-specific molecular markers10.1093/rheumatology/ket303 ↗
38. Adipose derived mesenchymal stem cells alleviated osteoarthritis and chondrocyte apoptosis through autophagy inducing
39. Rapamycin induced autophagy inhibits inflammation-mediated endplate degeneration by enhancing Nrf2/Keap1 signaling of cartilage endplate stem cells10.1002/stem.2999 ↗
40. Roles of autophagy in controlling stem cell identity: a perspective of self-renewal and differentiation10.1007/s00441-018-2829-7 ↗
41. Roles of Nrf2 in cell proliferation and differentiation10.1016/j.freeradbiomed.2015.06.030 ↗
42. Comparative analysis of adipose-derived mesenchymal stem cells isolated from abdominal and breast tissue10.1177/1090820X13496115 ↗
43. Genipin-cross-linked type II collagen scaffold promotes the differentiation of adipose-derived stem cells into nucleus pulposus-like cells10.1002/jbm.a.36325 ↗
44. FoxA2 regulates the type II collagen-induced nucleus pulposus-like differentiation of adipose-derived stem cells by activation of the Shh signaling pathway
45. A 3D-Bioprinted dual growth factor-releasing intervertebral disc scaffold induces nucleus pulposus and annulus fibrosus reconstruction
46. Regulation of the inflammatory cycle by a controllable release hydrogel for eliminating postoperative inflammation after discectomy
47. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy10.1016/S0301-472X(00)00160-0 ↗
48. International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials10.1016/j.jcyt.2015.11.008 ↗
49. Effects of kartogenin on the attenuated nucleus pulposus cell degeneration of intervertebral discs induced by interleukin-1 beta and tumor necrosis factor-alpha
50. Upregulation of SIRT1 by kartogenin enhances antioxidant functions and promotes osteogenesis in human mesenchymal stem cells10.1155/2018/1368142 ↗
51. The crosstalk between Sirt1 and Keap1/Nrf2/ARE anti-oxidative pathway forms a positive feedback loop to inhibit FN and TGF-beta 1 expressions in rat glomerular mesangial cells10.1016/j.yexcr.2017.09.042 ↗